nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinnarizine—CACNA1G—epilepsy syndrome	0.119	0.343	CbGaD
Cinnarizine—CACNA1H—epilepsy syndrome	0.108	0.309	CbGaD
Cinnarizine—CACNA1D—epilepsy syndrome	0.102	0.291	CbGaD
Cinnarizine—CACNA1G—Trimethadione—epilepsy syndrome	0.071	0.206	CbGbCtD
Cinnarizine—Modafinil—Fosphenytoin—epilepsy syndrome	0.0526	0.25	CrCrCtD
Cinnarizine—CACNA1I—Zonisamide—epilepsy syndrome	0.0472	0.137	CbGbCtD
Cinnarizine—Modafinil—Phenytoin—epilepsy syndrome	0.036	0.171	CrCrCtD
Cinnarizine—CACNA1G—Zonisamide—epilepsy syndrome	0.0355	0.103	CbGbCtD
Cinnarizine—Chlorcyclizine—Clobazam—epilepsy syndrome	0.0341	0.162	CrCrCtD
Cinnarizine—Modafinil—Carbamazepine—epilepsy syndrome	0.0332	0.158	CrCrCtD
Cinnarizine—Modafinil—Oxcarbazepine—epilepsy syndrome	0.0306	0.145	CrCrCtD
Cinnarizine—CACNA1H—Zonisamide—epilepsy syndrome	0.0288	0.0834	CbGbCtD
Cinnarizine—Diphenhydramine—Phenytoin—epilepsy syndrome	0.024	0.114	CrCrCtD
Cinnarizine—CYP2D6—epilepsy syndrome	0.0199	0.0572	CbGaD
Cinnarizine—CYP2A6—Amobarbital—epilepsy syndrome	0.0115	0.0333	CbGbCtD
Cinnarizine—CYP2B6—Fosphenytoin—epilepsy syndrome	0.00927	0.0269	CbGbCtD
Cinnarizine—CYP2A6—Propofol—epilepsy syndrome	0.00856	0.0248	CbGbCtD
Cinnarizine—CYP2A6—Phenobarbital—epilepsy syndrome	0.00818	0.0237	CbGbCtD
Cinnarizine—CYP2B6—Clobazam—epilepsy syndrome	0.00804	0.0233	CbGbCtD
Cinnarizine—CYP1A1—Propofol—epilepsy syndrome	0.00731	0.0212	CbGbCtD
Cinnarizine—CYP1A1—Phenobarbital—epilepsy syndrome	0.00699	0.0203	CbGbCtD
Cinnarizine—CYP2B6—Carbamazepine—epilepsy syndrome	0.00666	0.0193	CbGbCtD
Cinnarizine—CYP2B6—Primidone—epilepsy syndrome	0.00622	0.018	CbGbCtD
Cinnarizine—CYP2A6—Valproic Acid—epilepsy syndrome	0.00611	0.0177	CbGbCtD
Cinnarizine—CYP2B6—Phenytoin—epilepsy syndrome	0.00598	0.0173	CbGbCtD
Cinnarizine—CYP2B6—Propofol—epilepsy syndrome	0.00557	0.0162	CbGbCtD
Cinnarizine—CYP2B6—Phenobarbital—epilepsy syndrome	0.00533	0.0154	CbGbCtD
Cinnarizine—CYP2B6—Midazolam—epilepsy syndrome	0.00525	0.0152	CbGbCtD
Cinnarizine—CYP2C9—Trimethadione—epilepsy syndrome	0.00521	0.0151	CbGbCtD
Cinnarizine—CYP2B6—Diazepam—epilepsy syndrome	0.00505	0.0146	CbGbCtD
Cinnarizine—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0049	0.0142	CbGbCtD
Cinnarizine—CYP2B6—Valproic Acid—epilepsy syndrome	0.00398	0.0115	CbGbCtD
Cinnarizine—CYP1A2—Carbamazepine—epilepsy syndrome	0.00391	0.0113	CbGbCtD
Cinnarizine—CYP1A2—Primidone—epilepsy syndrome	0.00365	0.0106	CbGbCtD
Cinnarizine—CYP2C9—Carbamazepine—epilepsy syndrome	0.00352	0.0102	CbGbCtD
Cinnarizine—CYP2C9—Primidone—epilepsy syndrome	0.00329	0.00952	CbGbCtD
Cinnarizine—CYP1A2—Propofol—epilepsy syndrome	0.00327	0.00947	CbGbCtD
Cinnarizine—CYP2C9—Phenytoin—epilepsy syndrome	0.00316	0.00915	CbGbCtD
Cinnarizine—CYP1A2—Phenobarbital—epilepsy syndrome	0.00312	0.00905	CbGbCtD
Cinnarizine—CYP1A2—Diazepam—epilepsy syndrome	0.00296	0.00858	CbGbCtD
Cinnarizine—CYP2C9—Propofol—epilepsy syndrome	0.00294	0.00853	CbGbCtD
Cinnarizine—CYP2C9—Phenobarbital—epilepsy syndrome	0.00281	0.00815	CbGbCtD
Cinnarizine—CYP2D6—Propofol—epilepsy syndrome	0.00269	0.0078	CbGbCtD
Cinnarizine—CYP2C9—Diazepam—epilepsy syndrome	0.00267	0.00773	CbGbCtD
Cinnarizine—CYP1A2—Valproic Acid—epilepsy syndrome	0.00233	0.00676	CbGbCtD
Cinnarizine—CYP2C9—Valproic Acid—epilepsy syndrome	0.0021	0.00609	CbGbCtD
Cinnarizine—CACNA1D—ear—epilepsy syndrome	0.00158	0.0903	CbGeAlD
Cinnarizine—CACNA1I—telencephalon—epilepsy syndrome	0.00102	0.0585	CbGeAlD
Cinnarizine—DRD2—telencephalic ventricle—epilepsy syndrome	0.000881	0.0504	CbGeAlD
Cinnarizine—CACNA1F—head—epilepsy syndrome	0.000798	0.0456	CbGeAlD
Cinnarizine—CACNA1G—telencephalon—epilepsy syndrome	0.000702	0.0401	CbGeAlD
Cinnarizine—CACNA1I—cerebellum—epilepsy syndrome	0.000569	0.0325	CbGeAlD
Cinnarizine—DRD2—ganglion—epilepsy syndrome	0.000548	0.0313	CbGeAlD
Cinnarizine—CACNA1I—brain—epilepsy syndrome	0.000462	0.0264	CbGeAlD
Cinnarizine—CACNA1G—head—epilepsy syndrome	0.000437	0.025	CbGeAlD
Cinnarizine—DRD2—hindbrain—epilepsy syndrome	0.000416	0.0238	CbGeAlD
Cinnarizine—CACNA1G—nervous system—epilepsy syndrome	0.000414	0.0237	CbGeAlD
Cinnarizine—CACNA1D—forebrain—epilepsy syndrome	0.000412	0.0236	CbGeAlD
Cinnarizine—CACNA1G—central nervous system—epilepsy syndrome	0.000399	0.0228	CbGeAlD
Cinnarizine—CACNA1G—cerebellum—epilepsy syndrome	0.00039	0.0223	CbGeAlD
Cinnarizine—CACNA1C—forebrain—epilepsy syndrome	0.00038	0.0217	CbGeAlD
Cinnarizine—CACNA1D—telencephalon—epilepsy syndrome	0.000379	0.0217	CbGeAlD
Cinnarizine—CACNA1C—telencephalon—epilepsy syndrome	0.00035	0.02	CbGeAlD
Cinnarizine—CACNA1G—brain—epilepsy syndrome	0.000317	0.0181	CbGeAlD
Cinnarizine—CACNA1H—nervous system—epilepsy syndrome	0.000271	0.0155	CbGeAlD
Cinnarizine—CACNA1H—cerebellum—epilepsy syndrome	0.000255	0.0146	CbGeAlD
Cinnarizine—Difenoxin—OPRM1—epilepsy syndrome	0.000253	0.109	CrCbGaD
Cinnarizine—CYP2D6—hindbrain—epilepsy syndrome	0.00025	0.0143	CbGeAlD
Cinnarizine—DRD2—brainstem—epilepsy syndrome	0.000238	0.0136	CbGeAlD
Cinnarizine—CACNA1D—head—epilepsy syndrome	0.000236	0.0135	CbGeAlD
Cinnarizine—Diphenoxylate—OPRD1—epilepsy syndrome	0.000233	0.1	CrCbGaD
Cinnarizine—DRD2—forebrain—epilepsy syndrome	0.00023	0.0131	CbGeAlD
Cinnarizine—CACNA1D—nervous system—epilepsy syndrome	0.000224	0.0128	CbGeAlD
Cinnarizine—Flunarizine—CACNA1G—epilepsy syndrome	0.000223	0.0961	CrCbGaD
Cinnarizine—CACNA1C—head—epilepsy syndrome	0.000218	0.0125	CbGeAlD
Cinnarizine—CACNA1D—central nervous system—epilepsy syndrome	0.000215	0.0123	CbGeAlD
Cinnarizine—DRD2—telencephalon—epilepsy syndrome	0.000212	0.0121	CbGeAlD
Cinnarizine—CACNA1D—cerebellum—epilepsy syndrome	0.000211	0.012	CbGeAlD
Cinnarizine—CACNA1H—brain—epilepsy syndrome	0.000207	0.0118	CbGeAlD
Cinnarizine—CACNA1C—nervous system—epilepsy syndrome	0.000207	0.0118	CbGeAlD
Cinnarizine—Flunarizine—CACNA1H—epilepsy syndrome	0.000201	0.0865	CrCbGaD
Cinnarizine—CACNA1C—central nervous system—epilepsy syndrome	0.000199	0.0114	CbGeAlD
Cinnarizine—CACNA1C—cerebellum—epilepsy syndrome	0.000194	0.0111	CbGeAlD
Cinnarizine—Buclizine—CHRM1—epilepsy syndrome	0.000194	0.0835	CrCbGaD
Cinnarizine—CYP2A6—cerebellum—epilepsy syndrome	0.000189	0.0108	CbGeAlD
Cinnarizine—HRH1—forebrain—epilepsy syndrome	0.000182	0.0104	CbGeAlD
Cinnarizine—Diphenoxylate—OPRM1—epilepsy syndrome	0.000178	0.0769	CrCbGaD
Cinnarizine—CACNA1D—brain—epilepsy syndrome	0.000171	0.00977	CbGeAlD
Cinnarizine—HRH1—telencephalon—epilepsy syndrome	0.000167	0.00955	CbGeAlD
Cinnarizine—CACNA1C—brain—epilepsy syndrome	0.000158	0.00902	CbGeAlD
Cinnarizine—CYP2A6—brain—epilepsy syndrome	0.000153	0.00876	CbGeAlD
Cinnarizine—DRD2—midbrain—epilepsy syndrome	0.000152	0.00868	CbGeAlD
Cinnarizine—CYP2D6—brainstem—epilepsy syndrome	0.000143	0.00819	CbGeAlD
Cinnarizine—CYP2D6—forebrain—epilepsy syndrome	0.000138	0.0079	CbGeAlD
Cinnarizine—DRD2—head—epilepsy syndrome	0.000132	0.00753	CbGeAlD
Cinnarizine—CYP2D6—telencephalon—epilepsy syndrome	0.000127	0.00727	CbGeAlD
Cinnarizine—DRD2—nervous system—epilepsy syndrome	0.000125	0.00714	CbGeAlD
Cinnarizine—Clotrimazole—CYP11A1—epilepsy syndrome	0.000123	0.0529	CrCbGaD
Cinnarizine—DRD2—central nervous system—epilepsy syndrome	0.00012	0.00687	CbGeAlD
Cinnarizine—DRD2—cerebellum—epilepsy syndrome	0.000118	0.00672	CbGeAlD
Cinnarizine—Benzatropine—CHRM1—epilepsy syndrome	0.00011	0.0474	CrCbGaD
Cinnarizine—CYP1A1—head—epilepsy syndrome	0.00011	0.00627	CbGeAlD
Cinnarizine—CYP2B6—head—epilepsy syndrome	0.000107	0.00609	CbGeAlD
Cinnarizine—Sulfinpyrazone—ABCC2—epilepsy syndrome	0.000106	0.0456	CrCbGaD
Cinnarizine—HRH1—head—epilepsy syndrome	0.000104	0.00595	CbGeAlD
Cinnarizine—CYP1A1—nervous system—epilepsy syndrome	0.000104	0.00594	CbGeAlD
Cinnarizine—CYP2B6—nervous system—epilepsy syndrome	0.000101	0.00577	CbGeAlD
Cinnarizine—CYP1A1—central nervous system—epilepsy syndrome	0.0001	0.00572	CbGeAlD
Cinnarizine—HRH1—nervous system—epilepsy syndrome	9.86e-05	0.00564	CbGeAlD
Cinnarizine—CYP2B6—central nervous system—epilepsy syndrome	9.72e-05	0.00556	CbGeAlD
Cinnarizine—DRD2—brain—epilepsy syndrome	9.55e-05	0.00546	CbGeAlD
Cinnarizine—HRH1—central nervous system—epilepsy syndrome	9.5e-05	0.00543	CbGeAlD
Cinnarizine—Benzatropine—CHRM2—epilepsy syndrome	8.98e-05	0.0387	CrCbGaD
Cinnarizine—CYP1A1—brain—epilepsy syndrome	7.94e-05	0.00454	CbGeAlD
Cinnarizine—CYP2D6—head—epilepsy syndrome	7.92e-05	0.00452	CbGeAlD
Cinnarizine—CYP2B6—brain—epilepsy syndrome	7.72e-05	0.00441	CbGeAlD
Cinnarizine—HRH1—brain—epilepsy syndrome	7.54e-05	0.00431	CbGeAlD
Cinnarizine—CYP2D6—nervous system—epilepsy syndrome	7.51e-05	0.00429	CbGeAlD
Cinnarizine—CYP2D6—central nervous system—epilepsy syndrome	7.23e-05	0.00413	CbGeAlD
Cinnarizine—CYP2D6—cerebellum—epilepsy syndrome	7.06e-05	0.00404	CbGeAlD
Cinnarizine—Clotrimazole—ABCC2—epilepsy syndrome	6.75e-05	0.0291	CrCbGaD
Cinnarizine—Hydroxyzine—CYP2D6—epilepsy syndrome	6.37e-05	0.0275	CrCbGaD
Cinnarizine—Bifonazole—CYP2C19—epilepsy syndrome	6.24e-05	0.0269	CrCbGaD
Cinnarizine—CYP2D6—brain—epilepsy syndrome	5.74e-05	0.00328	CbGeAlD
Cinnarizine—Benzatropine—CYP2C19—epilepsy syndrome	5.54e-05	0.0239	CrCbGaD
Cinnarizine—Clotrimazole—CYP2C19—epilepsy syndrome	4.69e-05	0.0202	CrCbGaD
Cinnarizine—Diphenhydramine—CHRM2—epilepsy syndrome	4.62e-05	0.0199	CrCbGaD
Cinnarizine—Benzatropine—CYP2D6—epilepsy syndrome	4.11e-05	0.0177	CrCbGaD
Cinnarizine—Modafinil—CYP2C19—epilepsy syndrome	4.1e-05	0.0177	CrCbGaD
Cinnarizine—Sulfinpyrazone—ABCB1—epilepsy syndrome	3.89e-05	0.0168	CrCbGaD
Cinnarizine—Flunarizine—CYP2D6—epilepsy syndrome	3.72e-05	0.016	CrCbGaD
Cinnarizine—Clotrimazole—CYP2D6—epilepsy syndrome	3.48e-05	0.015	CrCbGaD
Cinnarizine—Diphenhydramine—CYP2C19—epilepsy syndrome	2.85e-05	0.0123	CrCbGaD
Cinnarizine—Clotrimazole—ABCB1—epilepsy syndrome	2.48e-05	0.0107	CrCbGaD
Cinnarizine—Diphenhydramine—CYP2D6—epilepsy syndrome	2.11e-05	0.0091	CrCbGaD
Cinnarizine—CYP1A1—Metabolism—CYP2C19—epilepsy syndrome	1.94e-06	2.56e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.94e-06	2.55e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—GLUL—epilepsy syndrome	1.93e-06	2.54e-05	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—CYP11A1—epilepsy syndrome	1.93e-06	2.54e-05	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—MTOR—epilepsy syndrome	1.92e-06	2.52e-05	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.92e-06	2.52e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.92e-06	2.52e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	1.9e-06	2.5e-05	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—CYP2D6—epilepsy syndrome	1.89e-06	2.48e-05	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.88e-06	2.48e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—PTK2B—epilepsy syndrome	1.88e-06	2.47e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—TSC1—epilepsy syndrome	1.88e-06	2.47e-05	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—ALB—epilepsy syndrome	1.86e-06	2.45e-05	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—PTGS2—epilepsy syndrome	1.85e-06	2.44e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—AGT—epilepsy syndrome	1.85e-06	2.44e-05	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.85e-06	2.43e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—PTK2B—epilepsy syndrome	1.85e-06	2.43e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—TSC1—epilepsy syndrome	1.85e-06	2.43e-05	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.84e-06	2.42e-05	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.84e-06	2.42e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—CCR2—epilepsy syndrome	1.83e-06	2.41e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—NTRK2—epilepsy syndrome	1.83e-06	2.41e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—SST—epilepsy syndrome	1.83e-06	2.41e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	1.82e-06	2.4e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	1.82e-06	2.4e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—AGT—epilepsy syndrome	1.82e-06	2.39e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—DUSP6—epilepsy syndrome	1.81e-06	2.38e-05	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—ADRA2A—epilepsy syndrome	1.8e-06	2.36e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—SST—epilepsy syndrome	1.8e-06	2.36e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—NTRK2—epilepsy syndrome	1.8e-06	2.36e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—CCR2—epilepsy syndrome	1.8e-06	2.36e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—ADRA2A—epilepsy syndrome	1.79e-06	2.35e-05	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—BCHE—epilepsy syndrome	1.79e-06	2.35e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—PLAT—epilepsy syndrome	1.78e-06	2.34e-05	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—AKT1—epilepsy syndrome	1.78e-06	2.34e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—DUSP6—epilepsy syndrome	1.78e-06	2.34e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	1.78e-06	2.34e-05	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—CASP3—epilepsy syndrome	1.76e-06	2.32e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.76e-06	2.31e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	1.75e-06	2.3e-05	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.75e-06	2.3e-05	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—CYP2D6—epilepsy syndrome	1.74e-06	2.29e-05	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	1.74e-06	2.29e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—AQP1—epilepsy syndrome	1.72e-06	2.27e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—CXCL12—epilepsy syndrome	1.72e-06	2.26e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—BDKRB2—epilepsy syndrome	1.72e-06	2.26e-05	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—POMC—epilepsy syndrome	1.72e-06	2.26e-05	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—CAT—epilepsy syndrome	1.72e-06	2.26e-05	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—JUN—epilepsy syndrome	1.71e-06	2.25e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—PRKCB—epilepsy syndrome	1.71e-06	2.25e-05	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—SLC2A1—epilepsy syndrome	1.71e-06	2.24e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—IL6ST—epilepsy syndrome	1.7e-06	2.24e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.7e-06	2.24e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.69e-06	2.22e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	1.69e-06	2.22e-05	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—PLCB1—epilepsy syndrome	1.69e-06	2.22e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—JUNB—epilepsy syndrome	1.69e-06	2.22e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—CNR1—epilepsy syndrome	1.69e-06	2.22e-05	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	1.69e-06	2.22e-05	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—TH—epilepsy syndrome	1.68e-06	2.21e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—PLCB1—epilepsy syndrome	1.68e-06	2.21e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.68e-06	2.21e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.67e-06	2.2e-05	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	1.67e-06	2.2e-05	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—MMP9—epilepsy syndrome	1.67e-06	2.19e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.66e-06	2.19e-05	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—ADRA2A—epilepsy syndrome	1.66e-06	2.18e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	1.66e-06	2.18e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	1.66e-06	2.18e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.66e-06	2.18e-05	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—BCHE—epilepsy syndrome	1.65e-06	2.17e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	1.65e-06	2.17e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—HTR7—epilepsy syndrome	1.65e-06	2.17e-05	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—PTGS2—epilepsy syndrome	1.63e-06	2.14e-05	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—AKT1—epilepsy syndrome	1.62e-06	2.13e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	1.62e-06	2.13e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—HBEGF—epilepsy syndrome	1.6e-06	2.1e-05	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	1.58e-06	2.07e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	1.57e-06	2.06e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—AKT3—epilepsy syndrome	1.57e-06	2.06e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	1.56e-06	2.05e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	1.56e-06	2.05e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—POMC—epilepsy syndrome	1.56e-06	2.05e-05	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	1.56e-06	2.05e-05	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—TH—epilepsy syndrome	1.55e-06	2.04e-05	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—GPX1—epilepsy syndrome	1.55e-06	2.04e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	1.54e-06	2.03e-05	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—SRC—epilepsy syndrome	1.54e-06	2.02e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—ADAM10—epilepsy syndrome	1.53e-06	2.02e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	1.53e-06	2.01e-05	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.53e-06	2.01e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—CCL2—epilepsy syndrome	1.53e-06	2.01e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	1.5e-06	1.98e-05	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.5e-06	1.97e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	1.5e-06	1.97e-05	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—VEGFA—epilepsy syndrome	1.5e-06	1.97e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.49e-06	1.96e-05	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.46e-06	1.92e-05	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.45e-06	1.91e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.45e-06	1.91e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.45e-06	1.91e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—S100B—epilepsy syndrome	1.45e-06	1.91e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.44e-06	1.89e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—SOCS3—epilepsy syndrome	1.43e-06	1.89e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—CDC42—epilepsy syndrome	1.43e-06	1.88e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.43e-06	1.88e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—S100B—epilepsy syndrome	1.42e-06	1.87e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.42e-06	1.87e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	1.41e-06	1.85e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	1.41e-06	1.85e-05	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—HMOX1—epilepsy syndrome	1.4e-06	1.85e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—AVP—epilepsy syndrome	1.39e-06	1.82e-05	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—CAT—epilepsy syndrome	1.38e-06	1.82e-05	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—AGT—epilepsy syndrome	1.36e-06	1.79e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—AVP—epilepsy syndrome	1.36e-06	1.79e-05	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—ABCB1—epilepsy syndrome	1.35e-06	1.77e-05	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—APOE—epilepsy syndrome	1.33e-06	1.75e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—HES1—epilepsy syndrome	1.31e-06	1.72e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.3e-06	1.72e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.3e-06	1.71e-05	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	1.3e-06	1.7e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—HES1—epilepsy syndrome	1.29e-06	1.69e-05	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—CAT—epilepsy syndrome	1.28e-06	1.68e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—FYN—epilepsy syndrome	1.27e-06	1.68e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.27e-06	1.67e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	1.27e-06	1.67e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	1.27e-06	1.67e-05	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—GPX1—epilepsy syndrome	1.25e-06	1.65e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—FYN—epilepsy syndrome	1.25e-06	1.65e-05	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.25e-06	1.64e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	1.25e-06	1.64e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	1.24e-06	1.64e-05	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	1.24e-06	1.64e-05	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.24e-06	1.64e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.24e-06	1.63e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.24e-06	1.63e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.23e-06	1.62e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.23e-06	1.62e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.22e-06	1.61e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.22e-06	1.61e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—NGF—epilepsy syndrome	1.21e-06	1.59e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.2e-06	1.58e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—NGF—epilepsy syndrome	1.19e-06	1.56e-05	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.19e-06	1.56e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	1.18e-06	1.55e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.18e-06	1.55e-05	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.17e-06	1.54e-05	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—TH—epilepsy syndrome	1.17e-06	1.54e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.16e-06	1.53e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—TH—epilepsy syndrome	1.16e-06	1.52e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	1.16e-06	1.52e-05	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—GPX1—epilepsy syndrome	1.16e-06	1.52e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	1.15e-06	1.52e-05	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—POMC—epilepsy syndrome	1.15e-06	1.51e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.14e-06	1.5e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	1.13e-06	1.49e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.11e-06	1.47e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.11e-06	1.46e-05	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—AGT—epilepsy syndrome	1.1e-06	1.44e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	1.1e-06	1.44e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—AGT—epilepsy syndrome	1.09e-06	1.44e-05	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—APOE—epilepsy syndrome	1.08e-06	1.42e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	1.08e-06	1.41e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—AGT—epilepsy syndrome	1.07e-06	1.41e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—APOE—epilepsy syndrome	1.07e-06	1.41e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.06e-06	1.39e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.05e-06	1.39e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—APOE—epilepsy syndrome	1.05e-06	1.38e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—KDR—epilepsy syndrome	1.05e-06	1.38e-05	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—ALB—epilepsy syndrome	1.04e-06	1.37e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—KDR—epilepsy syndrome	1.03e-06	1.36e-05	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—AGT—epilepsy syndrome	1.01e-06	1.33e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	1.01e-06	1.33e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	1.01e-06	1.32e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1e-06	1.32e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	9.94e-07	1.31e-05	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—APOE—epilepsy syndrome	9.93e-07	1.31e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	9.92e-07	1.31e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—TH—epilepsy syndrome	9.9e-07	1.3e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	9.88e-07	1.3e-05	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	9.75e-07	1.28e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.75e-07	1.28e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	9.67e-07	1.27e-05	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—CAT—epilepsy syndrome	9.62e-07	1.27e-05	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—AKT1—epilepsy syndrome	9.55e-07	1.26e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—CAT—epilepsy syndrome	9.54e-07	1.26e-05	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	9.36e-07	1.23e-05	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—AKT1—epilepsy syndrome	9.31e-07	1.23e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	9.28e-07	1.22e-05	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—POMC—epilepsy syndrome	9.24e-07	1.22e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—POMC—epilepsy syndrome	9.21e-07	1.21e-05	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	9.14e-07	1.2e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	9.04e-07	1.19e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	9.01e-07	1.19e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	8.85e-07	1.16e-05	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	8.7e-07	1.15e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—GPX1—epilepsy syndrome	8.63e-07	1.14e-05	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—POMC—epilepsy syndrome	8.53e-07	1.12e-05	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—ALB—epilepsy syndrome	8.43e-07	1.11e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	8.26e-07	1.09e-05	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—AKT1—epilepsy syndrome	8.18e-07	1.08e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—CAT—epilepsy syndrome	8.15e-07	1.07e-05	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	8.14e-07	1.07e-05	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	7.99e-07	1.05e-05	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	7.93e-07	1.04e-05	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—ALB—epilepsy syndrome	7.78e-07	1.02e-05	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—AGT—epilepsy syndrome	7.63e-07	1e-05	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—AGT—epilepsy syndrome	7.57e-07	9.95e-06	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	7.56e-07	9.94e-06	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—APOE—epilepsy syndrome	7.48e-07	9.84e-06	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	7.42e-07	9.76e-06	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—APOE—epilepsy syndrome	7.41e-07	9.75e-06	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	7.41e-07	9.75e-06	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	7.37e-07	9.7e-06	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	7.37e-07	9.7e-06	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	7.28e-07	9.58e-06	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	6.88e-07	9.05e-06	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	6.82e-07	8.97e-06	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	6.81e-07	8.96e-06	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.76e-07	8.89e-06	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	6.69e-07	8.81e-06	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	6.62e-07	8.71e-06	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	6.5e-07	8.55e-06	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—AGT—epilepsy syndrome	6.46e-07	8.51e-06	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	6.44e-07	8.48e-06	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—POMC—epilepsy syndrome	6.42e-07	8.45e-06	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—POMC—epilepsy syndrome	6.37e-07	8.38e-06	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—APOE—epilepsy syndrome	6.33e-07	8.33e-06	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	6.33e-07	8.32e-06	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	6.25e-07	8.22e-06	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	6.13e-07	8.07e-06	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	5.94e-07	7.82e-06	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—ALB—epilepsy syndrome	5.86e-07	7.71e-06	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	5.83e-07	7.67e-06	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—ALB—epilepsy syndrome	5.81e-07	7.64e-06	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	5.78e-07	7.61e-06	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	5.68e-07	7.47e-06	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—POMC—epilepsy syndrome	5.44e-07	7.16e-06	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	5.12e-07	6.74e-06	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	5.08e-07	6.68e-06	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—ALB—epilepsy syndrome	4.96e-07	6.53e-06	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—AKT1—epilepsy syndrome	4.59e-07	6.04e-06	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	4.34e-07	5.71e-06	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—AKT1—epilepsy syndrome	3.7e-07	4.87e-06	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	3.69e-07	4.86e-06	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	3.62e-07	4.77e-06	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—AKT1—epilepsy syndrome	3.42e-07	4.5e-06	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.57e-07	3.39e-06	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—AKT1—epilepsy syndrome	2.55e-07	3.36e-06	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	2.18e-07	2.87e-06	CbGpPWpGaD
